alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.69



ADDENDUM

SUBSEQUENT TO

the

LETTER AGREEMENT

dated February 20, 2008, made by and between Hollund Industrial Robotics Inc and Aquatic Cellulose International Corp.





Reference is herein made to the TigerLynk Purchase & Sale Agreement dated January 20, 2008, and the Letter Agreement dated February 20, 2008 made by and between Hollund Industrial Robotics Inc, a Canadian corporation (Buyer), and AQUATIC CELLULOSE INTERNATIONAL CORP, a Nevada corporation (Seller), collectively herein referred to as the parties.



This addendum is to document certain adjustments to the method of payment agreed to by the parties.



The parties hereby agree to the following;



(a)

Hollund will deposit 750,000 free trading shares of Hollund Industrial Inc., a Nevada registered company trading on the PinkSheets trading system, to the accounts of the Jim Lyons investment group. Hollund will make the deposit via Depository Trust and Clearing Corporation (DTCC), within two days after delivery of the account numbers and appropriate DTCC transfer information.

(b)

Aquatic will consider this deposit of shares as payment received for the March 1, 2008 payment due under the terms of the Purchas and Sale Agreement and Letter Agreement.



IN WITNESS WHEREOF, THIS ADDENDUM SHALL BE EFFECTIVE AS OF March 25, 2008.















\S\Lonnie Hayward

_\S\Sheridan Westgarde___

Lonnie Hayward, President

Sheridan Westgarde, CEO





# Endnotes

AQUATIC CELLULOSE INTERNATIONAL CORPORATION



HOLLUND INDUSTRIAL ROBOTICS INC.





Hollund Addendum March 25, 2008
BEVERLY NATIONAL BANK
EARNING YOUR TRUST SINCE 1802
240 Cabot Street, Beverly, Massachusetts 01915-4588
(978)922-2100

(LOGO) BEVERLY BANK
Member FDIC


As of and for the year  ended  December  31,  1999,  Beverly  National  Bank has
complied in all material respects with the minimum servicing standards set forth
in the Mortgage  Bankers  Association of America's  Uniform  Single  Attestation
Program for Mortgage Bankers.  As of and for this same period,  Beverly National
Bank had in effect a fidelity  bond  policy in the amount of  $4,000,000  and an
erors and omissions policy in the amount of $3,000,000.


Peter Simonsen
Senior V.P.&C.F.O
name and title Peter E. Simonsen


February 15, 2000
date


Cummings Center *  North Beverly Shopping Plaza *  South Hamilton * Topsfield
**Exhibit 32.1****CERTIFICATION**Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350,chapter 63 of title 18, United States Code), the undersigned officer of IPC Holdings, Ltd. (the“Company”), hereby certifies, to such officer’s knowledge, that:The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 (the“Report”) fully complies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934 and the information contained in the Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.        Dated:   April 27, 2007 /s/ James P. Bryce   Name:  James P. Bryce   Title:  Chief Executive Officer   The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-OxleyAct of 2002 (subsections (a) and (b) of Section 1350, chapter 63 of title 18, United States Code)and is not being filed as part of the Report.
Nathalie Thuy VAN, petitioner, v. LANGUAGE LINE LLC, et al.

No. 18-103.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Wallace G. CARLYLE, petitioner, v. Sherman CAMPBELL, Warden.

No. 18-8707.

Supreme Court of the United States

June 10, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
```
 
 
MSCI EAFE MINI INDEX - NYSE LIFFE                                    Code-244041
OPTION AND FUTURES COMBINED POSITIONS AS OF 12/06/11          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
(MSCI EAFE INDEX X $50)                              OPEN INTEREST:       44,172
COMMITMENTS
   1,859    2,117        0   38,425   39,777   40,284   41,894    3,888    2,278

CHANGES FROM 11/29/11 (CHANGE IN OPEN INTEREST:       -586)
     377      405        0   -1,626     -687   -1,249     -282      663     -304

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
     4.2      4.8      0.0     87.0     90.1     91.2     94.8      8.8      5.2

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:       51)
       4        5        0       24       31       28       36
 
 
MSCI EMERGING MKTS MINI INDEX - NYSE LIFFE                           Code-244042
OPTION AND FUTURES COMBINED POSITIONS AS OF 12/06/11          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
(MSCI EAFE INDEX X $50)                              OPEN INTEREST:       66,773
COMMITMENTS
   4,966   23,042      305   53,652   38,190   58,923   61,537    7,850    5,236

CHANGES FROM 11/29/11 (CHANGE IN OPEN INTEREST:      1,952)
     -76      737     -318      -25   -1,582     -419   -1,163    2,371    3,115

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
     7.4     34.5      0.5     80.3     57.2     88.2     92.2     11.8      7.8

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:       67)
      10        5        1       34       28       44       34
```

----

Updated December 9, 2011
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           6,700
<SECURITIES>                                         0
<RECEIVABLES>                                  327,000
<ALLOWANCES>                                     5,100
<INVENTORY>                                    348,900
<CURRENT-ASSETS>                               752,800
<PP&E>                                         554,800
<DEPRECIATION>                                 243,900
<TOTAL-ASSETS>                               1,237,100
<CURRENT-LIABILITIES>                          548,400
<BONDS>                                         79,600
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           200
<OTHER-SE>                                     397,400
<TOTAL-LIABILITY-AND-EQUITY>                 1,237,100
<SALES>                                      1,074,200
<TOTAL-REVENUES>                             1,074,200
<CGS>                                          812,700
<TOTAL-COSTS>                                  812,700
<OTHER-EXPENSES>                               225,800
<LOSS-PROVISION>                                   900
<INTEREST-EXPENSE>                               5,000
<INCOME-PRETAX>                                 29,800
<INCOME-TAX>                                    10,000
<INCOME-CONTINUING>                             19,800
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    19,800
<EPS-BASIC>                                        .85
<EPS-DILUTED>                                      .85


</TABLE>
Exhibit 31.3
                                  CERTIFICATION

I, PATRICIA GRAHAM, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Global Aircraft
Solutions, Inc.

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and

c) presented in this quarterly report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):

a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6. The registrant's other certifying officers and I have indicated in this
quarterly report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.


Date: November 30, 2005



/s/  Patricia Graham
-----------------------------
     Patricia Graham,
     Principal Financial Officer
##### 



EXHIBIT 32.2

Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Bert W. Hogue, Chief Financial Officer of Epoch Biosciences, Inc. (the
Company), certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
18 U.S.C. Section 1350, that:



|(1) |  | the Quarterly Report on Form 10-Q of the Company for the quarterly period
ended June 30, 2003 as filed with the Securities and Exchange Commission
on the date hereof (the Report) fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.
78m or 780(d)); and
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) |  | the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.                                                                                                                                                                     

|      |  |                |  |     |  |                                           
|----- |  | -------------- |  | --- |  | ------------------------------------------
|Date: |  | August 6, 2003 |  | By: |  | /s/ Bert W. Hogue                         
|      |  |                |  |     |  |                                           
|      |  |                |  |     |  | Bert W. Hogue                             
|      |  |                |  |     |  | Vice President and Chief Financial Officer
Presidential Documents

29019 

Federal Register 

Vol. 87, No. 91 

Wednesday, May 11, 2022 

Title 3— 

The President 

Notice of May 9, 2022 

Continuation of the National Emergency With Respect to the 

Central African Republic 

On May 12, 2014, by Executive Order 13667, the President declared a 

national emergency pursuant to the International Emergency Economic Powers Act (50 U.S.C. 1701–1706) to deal with the unusual and extraordinary 

threat to the national security and foreign policy of the United States constituted by the situation in and in relation to the Central African Republic, 

which has been marked by a breakdown of law and order; intersectarian 

tension; the pervasive, often forced recruitment and use of child soldiers; 

and widespread violence and atrocities, including those committed by Kremlin-linked and Yevgeniy Prigozhin-affiliated entities such as the Wagner 

Group, and which threatens the peace, security, or stability of the Central 

African Republic and neighboring states. 

The situation in and in relation to the Central African Republic continues 

to pose an unusual and extraordinary threat to the national security and 

foreign policy of the United States. For this reason, the national emergency 

declared in Executive Order 13667 on May 12, 2014, to deal with that 

threat must continue in effect beyond May 12, 2022. Therefore, in accordance 

with section 202(d) of the National Emergencies Act (50 U.S.C. 1622(d)), 

I am continuing for 1 year the national emergency declared with respect 

to the Central African Republic. This notice shall be published in the Federal 

Register and transmitted to the Congress. 

THE WHITE HOUSE, 

May 9, 2022. [FR Doc. 2022–10325 

Filed 5–10–22; 11:15 am] 

Billing code 3395–F2–P 


jspears on DSK121TN23PROD with PREZ DOC 3BIDEN.EPS</GPH>
##### 



Exhibit 11.1
 IPC HOLDINGS, LTD. AND SUBSIDIARIES
RECONCILIATION OF BASIC AND DILUTED NET INCOME PER COMMON
SHARE
  
  Net Income
    
    Shares outstanding(unaudited)
    
    and equivalents
    
    Amount per ShareQuarter ended March 31, 2007:Basic EPS (available to common shareholders)
    
    $
    73,021
    
    
    
    63,697,354
    
    
    $
    1.15Diluted EPS
    
    $
    77,207
    
    
    
    72,076,514
    
    
    $
    1.07Quarter ended March 31, 2006:Basic EPS (available to common shareholders)
    
    $
    58,413
    
    
    
    63,612,760
    
    
    $
    0.92Diluted EPS
    
    $
    62,647
    
    
    
    72,618,979
    
    
    $
    0.86
Charles R. BAKER, petitioner, v. Mark S. INCH, Secretary, Florida Department of Corrections, et al.

No. 18-8021.

Supreme Court of the United States

April 22, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

      ( print page 29384)    
                    Notice is hereby given that, on April 23, 2022, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), R Consortium, Inc. (“R Consortium”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Pfizer, Collegeville, PA, has been added as a party to this venture.                

Also, Alteryx Inc., Irvine, CA, has withdrawn as a party to this venture.

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and R Consortium intends to file additional written notifications disclosing all changes in membership.

                    On September 15, 2015, R Consortium filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on October 2, 2015 (80 FR 59815).                

                    The last notification was filed with the Department on February 2, 2022. A notice was published in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on March 11, 2022 (87 FR 14045).                

Suzanne Morris,

Chief, Premerger and Division Statistics, Antitrust Division.

[FR Doc. 2022-10274 Filed 5-12-22; 8:45 am]

BILLING CODE
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 10-KSB FILED
ON APRIL 6, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                         525,000
<SECURITIES>                                    89,000
<RECEIVABLES>                                7,089,000
<ALLOWANCES>                                   296,000
<INVENTORY>                                  3,628,000
<CURRENT-ASSETS>                            11,426,000
<PP&E>                                      10,251,000
<DEPRECIATION>                               3,569,000
<TOTAL-ASSETS>                              23,768,000
<CURRENT-LIABILITIES>                        8,188,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     9,558,000
<OTHER-SE>                                     246,000
<TOTAL-LIABILITY-AND-EQUITY>                23,768,000
<SALES>                                     11,939,000
<TOTAL-REVENUES>                            11,939,000
<CGS>                                        9,513,000
<TOTAL-COSTS>                                9,513,000
<OTHER-EXPENSES>                             2,040,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             358,000
<INCOME-PRETAX>                                (75,00)
<INCOME-TAX>                                    54,000
<INCOME-CONTINUING>                          (235,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (235,000)
<EPS-PRIMARY>                                   (0.06)
<EPS-DILUTED>                                   (0.06)
        

</TABLE>
<PAGE>   1



                                                                     EXHIBIT 4.9

                            STOCK PURCHASE AGREEMENT

CIMA Labs Inc.
10000 Valley View Road
Eden Prairie, Minnesota  55344

The undersigned (the "Investor"), hereby confirms its agreement with you as
follows:

1.   This Stock Purchase Agreement (the "Agreement") is made as of the date set
     forth below between CIMA Labs, Inc., a Delaware corporation (the
     "Company"), and the Investor.

2.   The Company has authorized the sale and issuance of up to 1,200,000 shares
     (the "Shares") of common stock of the Company, $.01 par value per share
     (the "Common Stock"), subject to adjustment by the Company's Board of
     Directors, to certain investors in a private placement (the "Offering").

3.   The Company and the Investor agree that the Investor will purchase from the
     Company and the Company will issue and sell to the Investor 600,000 shares,
     for a purchase price of $19.00 per share, or an aggregate purchase price of
     $11,400,000, pursuant to the Terms and Conditions for Purchase of Shares
     attached hereto as Annex I and incorporated herein by this reference as if
     fully set forth herein. Unless otherwise requested by the Investor,
     certificates representing the Shares purchased by the Investor will be
     registered in the Investor's name and address as set forth below.

4.   The Investor represents that, except as set forth below, (a) it has had no
     position, office or other material relationship within the past three years
     with the Company or its affiliates, (b) neither it, nor any group of which
     it is a member or to which it is related, beneficially owns (including the
     right to acquire or vote) any securities of the Company and (c) it has no
     direct or indirect affiliation or association with any NASD member.
     Exceptions:

                                       none
      --------------------------------------------------------------------------

        (If no exceptions, write "none." If left blank, response will be
                             deemed to be "none.")


Please confirm that the foregoing correctly sets forth the agreement between us
by signing in the space provided below for that purpose.

                                        DATED AS OF:  March 13, 2000

                                        Franklin Small Cap Growth Fund
                                        INVESTOR

                                        By:    /s/ Murray L. Simpson
                                             -----------------------
                                        Print Name:  Murray L. Simpson
                                        Title:  Vice President
                                        Address:  777 Mariners Island Boulevard,
                                        San Mateo, California  94404

AGREED AND ACCEPTED:
CIMA LABS INC.
By:    /s/ John M. Siebert
       -------------------
       John M. Siebert

Title: President and Chief Executive Officer